Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Sub Category
Head and Neck
Study Name
EA3132: Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing
Principal Investigator
Gordan Srkalovic
Study Information
Contact for Questions
Clinical Trials Office – 517.364.9400

Site view: at a glance